Information:
Fel:
ID
33474
Beskrivning
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01975389
Länk
https://clinicaltrials.gov/show/NCT01975389
Nyckelord
Versioner (1)
- 2018-12-10 2018-12-10 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
10 december 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Cardiovascular Disease NCT01975389
Eligibility Cardiovascular Disease NCT01975389
- StudyEvent: Eligibility
Similar models
Eligibility Cardiovascular Disease NCT01975389
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Lipid-lowering therapy
Item
must be on background lipid lowering treatment.
boolean
C0585943 (UMLS CUI [1])
High risk of Cardiovascular event
Item
must be at high risk of a cv event.
boolean
C0332167 (UMLS CUI [1,1])
C1320716 (UMLS CUI [1,2])
C1320716 (UMLS CUI [1,2])
Low density lipoprotein cholesterol measurement | High density lipoprotein cholesterol level
Item
must have an ldl c >/=100 mg/dl (2.6 mmol/l) or non hdl c >/=130 mg/dl (3.4 mmol/l).
boolean
C0202117 (UMLS CUI [1])
C0428471 (UMLS CUI [2])
C0428471 (UMLS CUI [2])
Low density lipoprotein cholesterol measurement | High density lipoprotein cholesterol level
Item
an ldl c <100 mg/dl (2.6 mmol/l) or non hdl c <130 mg/dl (3.4 mmol/l).
boolean
C0202117 (UMLS CUI [1])
C0428471 (UMLS CUI [2])
C0428471 (UMLS CUI [2])
Coronary revascularisation Planned | PCI Planned | CABG Planned | Revascularization Arterial Planned
Item
planned coronary (pci or cabg) or other arterial revascularization.
boolean
C0877341 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1532338 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0010055 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0581603 (UMLS CUI [4,1])
C0221464 (UMLS CUI [4,2])
C1301732 (UMLS CUI [4,3])
C1301732 (UMLS CUI [1,2])
C1532338 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0010055 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0581603 (UMLS CUI [4,1])
C0221464 (UMLS CUI [4,2])
C1301732 (UMLS CUI [4,3])
Congestive heart failure New York Heart Association Classification | Left ventricular ejection fraction Cardiac imaging
Item
new york heart association class iv congestive heart failure or left ventricular ejection fraction < 25% by cardiac imaging.
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C1096014 (UMLS CUI [2,2])
C1275491 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C1096014 (UMLS CUI [2,2])
Chronic Kidney Insufficiency | Creatinine clearance measurement MDRD formula | Dependence on dialysis due to end stage renal disease
Item
chronic renal insufficiency with creatinine clearance of <30 ml/min/1.73m^2 by mdrd formula or with end state renal disease on dialysis.
boolean
C0403447 (UMLS CUI [1])
C0373595 (UMLS CUI [2,1])
C3839656 (UMLS CUI [2,2])
C1997375 (UMLS CUI [3])
C0373595 (UMLS CUI [2,1])
C3839656 (UMLS CUI [2,2])
C1997375 (UMLS CUI [3])
Hemorrhagic stroke
Item
history of hemorrhagic stroke.
boolean
C0553692 (UMLS CUI [1])
Exposure to bococizumab | Exposure to PCSK9 Inhibitors Investigational
Item
prior exposure to bococizumab or other investigational pcsk9 inhibitor.
boolean
C0332157 (UMLS CUI [1,1])
C4043705 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C4051516 (UMLS CUI [2,2])
C1517586 (UMLS CUI [2,3])
C4043705 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C4051516 (UMLS CUI [2,2])
C1517586 (UMLS CUI [2,3])